Rarity Bioscience

BiotechnologySeedUppsala, Swedenraritybioscience.com

Latest round

Seed

Last raised

Feb 2023

Total raised

$3.1M

Investors

2

About Rarity Bioscience

Based in Sweden, and founded in 2021 by Lei Chen, Per Matsson, Ulf Landegren, and Mikael Smedeby, Rarity Bioscience operates as biotechnology research company that develops better ways to detect very small amounts of DNA sequence variants. Rarity Bioscience is a molecular diagnostics company that develops the superRCA technology for single variant mutation detection. The company's mission is to democratize mutation detection and improve clinical decisions and patient outcome by offering fast, sensitive, and reliable mutation detection technology. The company offers a various of applications, such as measurable residual disease (MRD) monitoring, which can be used to detect low levels of ctDNA in liquid biopsies, allowing for earlier detection of mutations, and analyzing both genomic and cell-free DNA in liquid biopsies, reducing the need for harmful tissue biopsies, and clinical trials, which are used to assess biomarkers in both pharma development and clinical testing.

Who invested in Rarity Bioscience

2 investors across 2 rounds

See all investors in Rarity Bioscience

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Feb 6, 2023

    Amount

    $0.5M

    Investors

    Locked

  2. Seed

    Nov 29, 2022

    Amount

    $2.6M

    Investors

    Locked

Questions about Rarity Bioscience

Who invested in Rarity Bioscience?

Rarity Bioscience has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Rarity Bioscience raised?

Rarity Bioscience has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Rarity Bioscience last raise money?

Rarity Bioscience's most recent round on record is a Seed, in Feb 2023.

What does Rarity Bioscience do?

Based in Sweden, and founded in 2021 by Lei Chen, Per Matsson, Ulf Landegren, and Mikael Smedeby, Rarity Bioscience operates as biotechnology research company that develops better ways to detect very small amounts of DNA sequence variants.

Where is Rarity Bioscience headquartered?

Rarity Bioscience is headquartered in Uppsala, Sweden.

Which VCs invest in companies like Rarity Bioscience?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Rarity Bioscience's stage. Their profiles are linked below.

Raising like Rarity Bioscience? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.